Cholestyramine and Metastasis - a phase IV clinical study of FDA data

Summary:

Metastasis is reported as a side effect among people who take Cholestyramine (cholestyramine), especially for people who are male, 60+ old, also take Lipitor, and have Carcinoid tumor.

The phase IV clinical study analyzes which people have Metastasis when taking Cholestyramine. It is created by eHealthMe based on reports of 9,676 people who have side effects when taking Cholestyramine from the FDA, and is updated regularly.

What is Cholestyramine?

Cholestyramine has active ingredients of cholestyramine. It is often used in diarrhea. eHealthMe is studying from 9,893 Cholestyramine users. Check the latest studies of Cholestyramine.

What is Metastasis?

Metastasis (spreadable cancer to other organ from origin) is found to be associated with 532 drugs and 842 conditions by eHealthMe. Check the latest studies of Metastasis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

9,676 people reported to have side effects when taking Cholestyramine.
Among them, 32 people (0.33%) have Metastasis.

Among these 32 people:

What is the gender of people who have Metastasis when taking Cholestyramine? *

female: 6.67 %
male: 93.33 %

What is the age of people who have Metastasis when taking Cholestyramine? *

What are other drugs people take besides Cholestyramine? *

What are other side effects people have besides Metastasis? *

Neck Pain: 31 people, 96.88%
Heart Rate Irregular: 30 people, 93.75%
Renal Cyst (kidney cyst): 30 people, 93.75%
Headache (pain in head): 30 people, 93.75%
Nasopharyngitis (inflammation of the nasopharynx): 30 people, 93.75%
High Blood Pressure: 30 people, 93.75%
Nerve Degeneration (weakness in functioning of nerve due to degeneration): 30 people, 93.75%
Oedema Peripheral (superficial swelling): 30 people, 93.75%
Visual Impairment: 30 people, 93.75%
Fatigue (feeling of tiredness): 30 people, 93.75%

What are the existing conditions these people have? *

Carcinoid Tumor: 30 people, 93.75%
Neuroendocrine Tumor: 4 people, 12.50%
Arrhythmias (irregular heartbeat): 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Cholestyramine and have Metastasis?

- Check whether Metastasis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cholestyramine:

Cholestyramine (9,893 reports)

Metastasis treatments and more:

Metastasis (11,222 reports)

Browse all side effects of Cholestyramine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Metastasis:

Metastasis (532 drugs)

Browse all the conditions that are associated with Metastasis:

Metastasis (842 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cholestyramine (the active ingredients of Cholestyramine) and Cholestyramine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.